Liraglutide
i-LAB
Novo Nordisk · Phase 3 · Status n/r · Enrollment 20
| Arm | Population | Dose | Weeks | Estimand | Weight change |
|---|---|---|---|---|---|
| Liraglutide 3.0 mg | Obesity + T2D | 3.0 mg | n/r | n/r | n/r |
Disease Pipeline Tools Obesity
Obesity
Programs, trials, and reported weight change for obesity and overweight.
Liraglutide
Novo Nordisk · Phase 3 · Status n/r · Enrollment 20
| Arm | Population | Dose | Weeks | Estimand | Weight change |
|---|---|---|---|---|---|
| Liraglutide 3.0 mg | Obesity + T2D | 3.0 mg | n/r | n/r | n/r |